WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2023

Dec 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2023-12-01

Reporting Person: Winters Chad (VP, Chief Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-01	Common Stock	M	456	$143.43	Acquired	1941.698	Direct
2023-12-01	Common Stock	S	1013	$349.0042	Disposed	1269.698	Direct
2023-12-01	Common Stock	M	341	$173.22	Acquired	2282.698	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-01	Stock Options (Right to Buy)	$143.43	M	456	Disposed	2029-10-29	Stock Options (Right to Buy) (456)	Direct
2023-12-01	Stock Options (Right to Buy)	$173.22	M	341	Disposed	2030-02-18	Stock Options (Right to Buy) (341)	Direct